Physician profile
Sharon George
NPI 1447870951
$816.44
in general payments reported to CMS, 2019-2025
16 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.79 · 2024: $421 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $159.08 | 2021-2025 | |
| Lilly USA, LLC | $156.46 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Exact Sciences Corporation | $84.44 | 2024-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.49 | 2024-2025 | Xifaxan, Trulance |
| Novo Nordisk INC | $48.25 | 2024 | Wegovy |
| Inspire Medical Systems, INC. | $44.63 | 2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $37.51 | 2024-2025 | |
| Glaxosmithkline, LLC. | $36.41 | 2024 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $34.72 | 2025 | |
| Amgen INC. | $27.72 | 2025 | Evenity |
| Shield Therapeutics INC | $25.36 | 2024 | |
| Corcept Therapeutics | $24.80 | 2025 | Korlym |
| Biotronik Nro, INC. | $23.48 | 2024 | Prospera |
| Dexcom, INC. | $22.15 | 2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $20.45 | 2024 | Airsupra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $19.49 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.